²é¿´: 387  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

23010402

¾èÖú¹ó±ö (ÖøÃûдÊÖ)

[ÇóÖú] ·­ÒëÇóÖú

Geometric mean BIBW 2992 plasma concentration¨Ctime profiles after single andmultiple dosing are shown in Figure 1. No deviation from dose-proportional behavior was observed over the evaluated dose range. Across doses, the terminal half-life of BIBW2992 ranged between 21.3 to 27.7 hours on day 1 and 22.3 to 67.0 hours on day 27. Steady-state was reached after 7 days of initiating
continuous BIBW 2992 dosing, with no evidence of further drug
accumulation or decrease through subsequent cycles. The poor association between apparent total body clearance and both weight and
body-surface area justified the fixed oral dosing of BIBW 2992 (Appendix Fig A2, online only). Table 3 summarizes the PK parameters of
BIBW 2992 on days 1 and 27 (steady-state) after single and multiple
doses, and Appendix Table A2 (online only) presents the PK param-
eters of drug under fed and fasted conditions. High-fat food intake
before single oral BIBW 2992 doses of 40 mg/d significantly altered
and decreased drug disposition.

» ²ÂÄãϲ»¶

¶þÊ®Äêǰ̫С£¬¶þÊ®ÄêºóÌ«ÀÏ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

alvarohao

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
sltmac(½ð±Ò+1): 2011-11-16 11:06:56
23010402(½ð±Ò+5, ·­ÒëEPI+1): лл~ 2011-11-16 17:27:59
ͼ1ÏÔʾÁ˸øÒ©µ¥¼ÁÁ¿ºÍ¶à¼ÁÁ¿ºóµÄBIBW2992(°¢·¨ÌæÄá)Ѫ½¬Å¨¶ÈµÄ¼¸ºÎƽ¾ùÖµÓëʱ¼äµÄ¹ØÏµÍ¼¡£ÔÚËùÆÀ¹ÀµÄ¼ÁÁ¿·¶Î§ÄÚûÓз¢ÏÖ¼ÁÁ¿ÓÐÆ«Àë±ÈÀý¹ØÏµµÄÐÐΪ¡£ÔÚËùÓмÁÁ¿ÖУ¬BIBW2992µÄ°ëË¥ÆÚÔÚµÚÒ»ÌìΪ21.3µ½27.7Сʱ£¬ÔÚµÚ27ÌìΪ22.3µ½67.0Сʱ¡£ÔÚ¿ªÊ¼Á¬Ðø¸øÒ©BIBW2992ºó7Ìì´ïµ½Îȶ¨×´Ì¬£¬ÔÚ½ÓÏÂÀ´µÄÖÜÆÚÖÐûÓнøÒ»²½µÄ»ýÀÛ»ò¼õÉÙ¡£Í¨¹ýÃ÷ÏÔµÄÈ«ÉíÇå³ýÂÊÓëÌåÖØºÍÌå±íÃæ»ýÖ®¼ä΢ÈõµÄ¹ØÏµµ÷ÕûÁËBIBW2992µÄ¹Ì¶¨¿Ú·þ¼ÁÁ¿£¨¸½Â¼Í¼A2£¬Ö»ÔÚÏßÌṩ£©¡£±í3×ܽáÁËÔÚ¸øÒ©BIBW2992µ¥¼ÁÁ¿ºÍ¶à¼ÁÁ¿ºóµÚÒ»Ììµ½µÚ27Ì죨Îȶ¨×´Ì¬£©µÄPK²ÎÊý£¬²¢ÇÒ¸½Â¼±íA2£¨Ö»ÔÚÏßÌṩ£©¸ø³öÁËÔÚÒûʳºÍ¿Õ¸¹Ìõ¼þÏÂÒ©ÎïµÄPK²ÎÊý¡£ÔÚ¿Ú·þBIBW2992µÄ40mg/d£¨ºÁ¿Ë/Ì죩µ¥¼ÁÁ¿Ö®Ç°ÉãÈ¡¸ßÖ¬·¾Ê³Î»áÃ÷ÏԵĸıäºÍÏ÷ÈõÒ©Îï´¦Öá£
ÇóŒ?„“У¬„îÖ¾ˆD?Š£¡
2Â¥2011-11-16 10:21:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 23010402 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼Á +5 repeatt?t 2026-02-28 5/250 2026-03-01 11:43 by ÍõΰҪÉϰ¶°¡
[¿¼ÑÐ] 317Ò»Ö¾Ô¸»ªÄÏÀí¹¤µçÆø¹¤³ÌÇóµ÷¼Á +6 Soliloquy_Q 2026-02-28 11/550 2026-03-01 11:14 by ¸èliekkas
[¿¼ÑÐ] ѰÕÒµ÷¼Á +4 LYidhsjabdj 2026-02-28 4/200 2026-03-01 10:56 by sunny81
[¿¼ÑÐ] 291·Ö¹¤¿ÆÇóµ÷¼Á +7 science¶ö¶ö 2026-03-01 8/400 2026-03-01 10:43 by sunny81
[˶²©¼ÒÔ°] ²©Ê¿×Ô¼ö +6 ¿ÆÑй·111 2026-02-26 10/500 2026-03-01 10:02 by ¿ÆÑй·111
[¿¼ÑÐ] 272Çóµ÷¼Á +4 ²Ä×ÏÓл¯ 2026-02-28 4/200 2026-03-01 09:20 by L135790
[¿¼ÑÐ] 298Çóµ÷¼Á +5 axyz3 2026-02-28 5/250 2026-03-01 06:45 by Áõ±ø
[¿¼ÑÐ] 272Çóµ÷¼Á +4 ÌïÖÇÓÑ 2026-02-28 4/200 2026-03-01 06:43 by Áõ±ø
[»ù½ðÉêÇë] ÃæÉÏÄ£°å¸Ä²»ÁËÒ³±ß¾à°É£¿ +5 ieewxg 2026-02-25 6/300 2026-03-01 00:10 by addressing
[¿¼ÑÐ] »¯¹¤×¨Ë¶348£¬Ò»Ö¾Ô¸985Çóµ÷¼Á +4 ¸¥¸ñ¸ö 2026-02-28 6/300 2026-02-28 22:00 by wang_dand
[¿¼ÑÐ] 292Çóµ÷¼Á +3 yhk_819 2026-02-28 3/150 2026-02-28 21:57 by gaoxiaoniuma
[¿¼ÑÐ] 295Çóµ÷¼Á +5 19171856320 2026-02-28 5/250 2026-02-28 21:39 by gaoxiaoniuma
[¿¼²©] 26É격 +4 ÏëÉ격£¡ 2026-02-26 4/200 2026-02-28 21:37 by limorning
[¿¼ÑÐ] 264Çóµ÷¼Á +3 °ÍÀ­°ÍÀ­¸ù556 2026-02-28 3/150 2026-02-28 21:31 by gaoxiaoniuma
[¿¼ÑÐ] 276Çóµ÷¼Á +3 ·lyh123 2026-02-28 4/200 2026-02-28 19:45 by ·lyh123
[¿¼ÑÐ] 0856²ÄÁÏÇóµ÷¼Á +10 hyf hyf hyf 2026-02-28 11/550 2026-02-28 18:50 by Î޼ʵIJÝÔ­
[¸ß·Ö×Ó] Çó»·ÑõÊ÷Ö¬Ñз¢1Ãû +3 Ëïxc 2026-02-25 11/550 2026-02-28 16:57 by ichall
[¿¼ÑÐ] 265·ÖÇóµ÷¼Á²»µ÷רҵºÍѧУÓÐÐÐѧÉÏ¾Í +4 ÀñÌö¡Õæ258 2026-02-28 6/300 2026-02-28 16:18 by Çóµ÷¼Ázz
[¿¼ÑÐ] 304Çóµ÷¼Á +5 ÂüÊâ2266 2026-02-28 6/300 2026-02-28 12:44 by ÃÔºýCCPs
[»ù½ðÉêÇë] ÃæÉÏ¿ÉÒÔ³¬¹ý30Ò³°É£¿ +12 °¢À­¹±aragon 2026-02-22 13/650 2026-02-26 22:09 by Hahaxia
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û